Ligand Pharmaceuticals is a biopharmaceutical company built on the concept of developing or acquiring royalty revenue-generating assets and merging them with a lean corporate cost structure. Ligand offers investors an opportunity to invest in the pharmaceutical industry by diversifying the portfolio of assets across numerous technology types, therapeutic areas, drug targets, and industry partners. The company’s diversified asset portfolio includes therapies that address unmet medical needs for a vast range of diseases. For more information visit the company’s Web site at www.ligand.com

ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year’s annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 11-14. Bringing together executives from more than 400 growth companies, the 24th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com

Let us hear your thoughts below: